Table 5.
Caffeine intake, quartiles (mg/d) |
||||
---|---|---|---|---|
0–137.0 | 138.5–231.0 | 251.5–391.5 | 411.0–1872.5 | |
No. of men | 109 | 99 | 105 | 105 |
Alzheimer lesions | ||||
No. of cases | 27 | 25 | 25 | 26 |
Age-adjusted | 1.00 | 1.00 (0.53–1.90) | 0.98 (0.52–1.84) | 1.03 (0.55–1.93) |
Multivariable-adjusted* | 1.00 | 1.10 (0.55–2.18) | 0.96 (0.48–1.90) | 0.85 (0.42–1.73) |
Microvascular ischemic lesions | ||||
No. of cases | 43 | 46 | 31 | 34 |
Age-adjusted | 1.00 | 1.31 (0.75–2.27) | 0.64 (0.36–1.12) | 0.73 (0.42–1.28) |
Multivariable-adjusted* | 1.00 | 1.27 (0.72–2.26) | 0.66 (0.37–1.20) | 0.79 (0.43–1.45) |
Generalized atrophy | ||||
No. of cases | 54 | 40 | 46 | 48 |
Age-adjusted | 1.00 | 0.66 (0.37–1.16) | 0.80 (0.46–1.40) | 0.87 (0.50–1.52) |
Multivariable-adjusted* | 1.00 | 0.68 (0.38–1.22) | 0.87 (0.49–1.55) | 1.01 (0.56–1.84) |
Cortical Lewy bodies | ||||
No. of cases | 19 | 14 | 18 | 12 |
Age-adjusted | 1.00 | 0.76 (0.36–1.62) | 0.99 (0.49–2.03) | 0.62 (0.28–1.36) |
Multivariable-adjusted* | 1.00 | 0.82 (0.38–1.80) | 1.10 (0.52–2.31) | 0.71 (0.30–1.66) |
Hippocampal sclerosis | ||||
No. of cases | 13 | 9 | 8 | 8 |
Age-adjusted | 1.00 | 0.71 (0.29–1.77) | 0.61 (0.24–1.56) | 0.63 (0.25–1.60) |
Multivariable-adjusted* | 1.00 | 0.67 (0.25–1.78) | 0.62 (0.23–1.71) | 0.77 (0.27–2.20) |
Any lesions | ||||
No. of cases | 87 | 70 | 71 | 68 |
Age-adjusted | 1.00 | 0.59 (0.31–1.12) | 0.53 (0.28–1.00) | 0.46 (0.25–0.86) |
Multivariable-adjusted* | 1.00 | 0.61 (0.31–1.20) | 0.57 (0.30–1.10) | 0.45 (0.23–0.89) |
Adjusts for age at death, physical activity index, smoking, years of education, APOE ε4 status, elevated cholesterol, and hypertension. LRT p, trend=0.04 for any lesions.